Skip to content

Report reveals biotech as the biggest driver for cancer treatments

Global pharmaceutical and biopharmaceutical open access capability platform, WuXi AppTec, has published a report on immunotherapy, identifying that smaller biotech firms and early-stage companies will be the biggest driver behind therapy innovation.

Report reveals biotech as the biggest driver for cancer treatments
Published: | 1 min read

Global pharmaceutical and biopharmaceutical open access capability platform, WuXi AppTec, has published a report on immunotherapy, identifying that smaller biotech firms and early-stage companies will be the biggest driver behind therapy innovation.

Immunotherapy research

The report, titled ‘Inside Perspectives: Will Immunotherapy Knock Out Cancer?’, predicts that in the next decade there will be a significant increase in the number of breakthroughs in immunotherapy as the industry becomes more knowledgeable to the human’s immune system.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information